HR 3539
Leadership in CET Act
TL;DR
Rep. Lance Gooden (R-TX) introduced the Leadership in Critical and Emerging Technologies (CET) Act, which aims to strengthen U.S. competitiveness in AI, quantum computing, biotech, and other emerging tech sectors. The bill is in early committee stages at the House Judiciary Committee and appears focused on national strategy rather than direct regulation of businesses.
How This Might Impact Your Business
Tech companies working in AI, quantum computing, semiconductors, and biotech would likely see federal support for R&D and workforce development, though specifics depend on final bill text.
No new compliance requirements or penalties are apparent at this stage, so no immediate operational changes are required.
Defense contractors and companies with government contracts in critical technology areas could see expanded procurement opportunities.
Universities, national labs, and research-heavy companies may gain access to new federal funding streams for CET research.
Companies with China exposure in critical tech supply chains should watch for potential export control or investment screening provisions that often accompany 'leadership' bills.
The bill sits in the House Judiciary Committee, suggesting possible provisions on IP, antitrust, or foreign investment review rather than pure R&D funding.
Small and mid-size tech firms in emerging sectors could benefit from grant or partnership programs if included in the final version.
What Should You Do
Ask your government affairs or legal team to pull the full bill text and flag any export control, foreign investment, or IP provisions relevant to your business.
If you operate in AI, quantum, biotech, or semiconductors, have your business development team monitor for new federal grant or partnership opportunities tied to this bill.
Track the bill's progress through House Judiciary; request notification when committee hearings are scheduled or a markup is announced.
Review your current exposure to Chinese suppliers or investors in critical tech areas, as competitiveness bills frequently expand CFIUS or export restrictions.
No immediate compliance action is needed; revisit if the bill advances out of committee.
Who It Affects
Sponsors
Status Timeline
committee
Referred to the House Committee on the Judiciary.
May 21, 2025